
The Review: nature.com/articles/s42255-0… Our HAMSAB trial: nature.com/articles/s44161-0…

Viertel @nhmrc & @HeartFoundation Fellow & #Hypertension Lab Head @MonashVHI /BDI. Gut microbes, 🐶 lover, #Cancer survivor @Science_Academy Gottschalk🏅she/her

The Review: nature.com/articles/s42255-0… Our HAMSAB trial: nature.com/articles/s44161-0…

Practical point: sodium butyrate is sold OTC in many countries. The only RCT testing it in untreated hypertension found BP rose Our call: measure cardiovascular endpoints (ideally ABPM) in SCFA trials across all indications Otherwise we miss harms, not just benefits

Same molecule. Opposite effects The variable isn't dose or plasma concentration — it's where the SCFA reaches the gut. Absorbed high in the small intestine ≠ delivered to the distal lumen

Two RCTs in untreated hypertension disagree: HAMSAB (colonic release) → 24h systolic BP ↓6.1 mmHg Oral sodium butyrate → daytime systolic BP ↑9.6 mmHg A butyrate enema lowered BP again, with no rise in circulating butyrate

New Correspondence in @NatMetabolism with @rikeishm A recent Review assessed the translational potential of short-chain fatty acids — but skipped blood pressure, where the human evidence is arguably strongest nature.com/articles/s42255-0…

If you are in Australia and interested in supplements for your gut microbes, we would love to hear your opinions and thoughts Please check out our survey 👇👇👇 redcap.helix.monash.edu/surv…

As Brené Brown says, 'clear is kind, unclear is unkind' Having clarity of who you are as a team and setting (and holding) boundaries is essential for thriving research cultures That's a reason why we have a lab manual, just updated 🥳 Check it out 👇 marqueslab.com/manual

As we transition to managing CKM syndrome under the new frameworks, the gut microbiome must move from the periphery to a core therapeutic target

Just a week ago, the global medical community recognised these conditions as a single, interconnected multi-organ continuum, publishing the 2026 AHA/ACC/ADA/ASN Clinical Practice Guidelines for CKM Syndrome in @JACC: ahajournals.org/doi/10.1161/…

This is important because the concept of Cardiovascular-Kidney-Metabolic (CKM) was introduced in 2023: ahajournals.org/doi/10.1161/…

When poor diets (low fibre, high meat) disrupt the gut microbiota, it triggers a toxic cascade Our team, led by first author @ChudanXu and @MatthewSnelson, mapped out how gut-derived uremic toxins cross a leaky gut barrier to fuel the entire CKM continuum

📢New paper alert Cardiovascular-Kidney-Metabolic (CKM) syndrome is officially recognised as a single, multi-organ continuum Our new review in Gut Microbes points to a critical, overlooked culprit: the gut microbiome ➡️tandfonline.com/doi/full/10.…

We’ve also been digging into GPR65 Our latest work shows how GPR65 sensing in T-cells is a vital link between gut acidity and systemic inflammation that regulates blood pressure GPR65 pre-print: biorxiv.org/content/10.1101/…

In our Clinical Science paper, we showed that GPR68 is essential for fibre to lower blood pressure Without this "sensor," the benefits of a high-fibre diet are lost🧬🚫 GPR68 study: pubmed.ncbi.nlm.nih.gov/4056…

How does the body "sense" this acidity? Enter pH-sensing G-protein coupled receptors (GPCRs) Our team recently identified two major players in this gut-to-host communication: GPR68 and GPR65

Does this actually happen in humans? Yes Our recent clinical data show that individuals with hypertension have a significantly higher (more alkaline) gut pH compared to those with healthy blood pressure The clinical data (nearly accepted!): medrxiv.org/content/10.64898…